Lv4
540 积分 2024-10-16 加入
Patient selection for PRRT rechallenge in neuroendocrine tumors: impact of initial response duration on outcomes
17小时前
已完结
Clinical value of per-treatment whole-body single-time-point automated dosimetry for [(177)Lu]Lu-PSMA-617 therapy in metastatic castration-resistant prostate cancer
5个月前
已完结
[ 177 Lu]Lu-DOTATATE and [ 177 Lu]Lu-DOTA-IBA Cocktail Therapy for Metastatic Small Cell Lung Cancer: Possible Applications in Clinical Practice
6个月前
已关闭
皖公网安备34019202002308
